The framework includes 6 domains designed to immediately empower students in community pharmacies.
Precision dosing technology uses multiple patient-specific factors to individualize medication doses, helping clinicians reduce medication errors that lead to adverse events.
Although pharmacotherapy is considered for the treatment of insomnia, medication should not be the sole treatment for individuals diagnosed with insomnia.
This year’s event from June 20 to 21, 2024, in Austin, Texas, will offer 4.25 BCOP CE hours.
Students may be hesitant to discuss migraines, which can lead to absences, difficulties in personal life, financial burdens, and poor mental health.
Pediatric guidelines suggest 10 days of therapy for community-acquired pneumonia, but recent data support shortening therapy duration.
FDA approvals of vaccines usually take 10 to 15 years, but the pandemic necessitates emergency action.
Motivational Interviewing is a collaborative conversation style that can empower patients to stay the course and achieve better outcomes.
Most pharmacists and technicians are unaware of resources that aid in communication.
Oncology pharmacists are as diverse as the cancers they manage and have key roles in the following areas of the cancer care continuum.
With respiratory syncytial virus vaccine development for infants and children proceeding slowly, therapeutic developers have focused on passive immunity
A shortage of pharmacists led to a call for pharmacy education in Alaska that echoed across the state.
Cardioprotective antihyperglycemic agents are underutilized for inpatient care in heart failure patients. Lack of use can lead to preventable patient deaths and hospital readmissions.
Over the next few years, undiagnosed breast cancer cases may add to the demand for more rigorous end-stage treatments and therapeutics.
The FDA's current way of inspecting facilities for quality control is badly outdated and is politically unworkable, unreliable, and unsafe.
Data show that dose-response relationships and long-term safety of ICS in people with chronic obstructive pulmonary disease are unclear and require further investigation.
PAPs can significantly reduce OOP costs for patients.
Advancements in genomic and mutational analysis show that up to 60% of adenocarcinomas and up to 50% to 80% of squamous cell carcinomas (SCC) have a known oncogenic driver mutation.
In terms of science and technology, the health care community has everything needed to clinically implement pharmacogenomics testing.
The FDA approved the first vaccine for dengue disease in May 2019.
Pharmacists will have the opportunity to use their knowledge of biosimilars to reinforce their benefits, safety, and efficacy.
New standards from the National Council for Prescription Drug Programs could drive changes that improve patient safety by optimizing drug therapy to reduce the risk of harm and improve health and well-being before a medication is dispensed.
Many patients have baseline risk factors present at diagnosis because of older age and disease-related elements.
This review discusses the prevalence, mechanisms of development, and evolving treatment landscape in chronic lymphocytic leukemia.
The health care industry must cultivate volunteer support to maintain a positive impact on vaccination rates.
Facilitating environmental cues that members of the LGBTQ+ community look for to signify that they are in a safe space is an especially important element for the LGBTQ+ community.
Management of heart failure focuses on avoiding reversible precipitants and optimizing guideline-directed therapy to lower mortality and hospitalizations.